No accelerated progression of subclinical atherosclerosis with integrase strand transfer inhibitors compared to non-nucleoside reverse transcriptase inhibitors
INSTI-based regimens are not associated with increased progression of subclinical atherosclerosis when compared to NNRTI.
Authors
- Paula Mascarell (ORCID: https://orcid.org/0000-0002-0566-0935)
- Félix Gutiérrez (ORCID: https://orcid.org/0000-0002-9485-6867)
- Ángela Botella (ORCID: https://orcid.org/0000-0002-1599-0030)
- Vanesa Agulló (ORCID: https://orcid.org/0000-0002-7036-2184)
- José Alberto García (ORCID: https://orcid.org/0000-0002-1203-7260)
- Javier García‐Abellán (ORCID: https://orcid.org/0000-0002-5217-3726)
- Marta Fernández‐González (ORCID: https://orcid.org/0000-0001-9949-8504)
- Mar Masiá (ORCID: https://orcid.org/0000-0001-9878-2458)
- Sergio Padilla (ORCID: https://orcid.org/0000-0002-8420-7310)
Institutions
- Universitat de Miguel Hernández d'Elx (ES)
- Instituto de Salud Carlos III (ES)
- Centro de Investigación Biomédica en Red (ES)
- Hospital General Universitario de Elche (ES)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1093/jac/dkae383
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Generalitat Valenciana
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
- Instituto de Salud Carlos III
- European Regional Development Fund
- Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana
- Spanish National Plan for Scientific and Technical Research and Innovation
- FP7 Science in Society